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Background: The principal aim of this study was to evaluate the feasibility of incorporating four-dimensional
(4D)-computed tomography (CT)-based functional information into treatment planning and to evaluate the
potential benefits of individualized beam setups to better protect lung functionality in patients with non-small
cell lung cancer (NSCLC).
Methods: Peak-exhale and peak-inhale CT scans were carried out in 16 patients with NSCLC treated with
intensity-modulated radiotherapy (IMRT). 4D-CT-based ventilation information was generated from the two sets
of CT images using deformable image registration. Four kinds of IMRT plans were generated for each patient:
two anatomic plans without incorporation of ventilation information, and two functional plans with ventilation
information, using either five equally spaced beams (FESB) or five manually optimized beams (FMOB). The dosimetric
parameters of the plans were compared in terms of target and normal tissue structures, with special focus on dose
delivered to total lung and functional lung.
Results: In both the anatomic and functional plans, the percentages of both the functional and total lung regions
irradiated at V5, V10, and V20 (percentage volume irradiated to >5, >10 and >20 Gy, respectively) were significantly
lower for FMOB compared with FESB (P < 0.05), but there was no significant difference for V30 (P > 0.05). Compared
with FESB, a greater degree of sparing of the functional lung was achieved in functional IMRT plans with optimal beam
arrangement, without compromising target volume coverage or the irradiated volume of organs at risk, such as the
spinal cord, esophagus, and heart.
Conclusions: Pulmonary ventilation image-guided IMRT planning with further optimization of beam arrangements
improves the preservation of functional lung in patients with NSCLC.
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Plan optimizationBackground
Radiation therapy (RT) plays a significant role in the
curative treatment of surgically inoperable non-small cell
lung cancer (NSCLC). Radiation pneumonitis (RP) is the
most common complication of RT for NSCLC, and its
occurrence and severity are closely correlated with the
mean lung dose, total lung volume irradiated to >20 Gy
(V20), location of the tumor, pulmonary function, and* Correspondence: gthzsx@163.com
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unless otherwise stated.simultaneous or sequential chemotherapy [1-4]. Graham
et al. [5] showed that when the V20 was <22%, the incidence
of RP within 2 years was zero; however, the incidences of
RP within 2 years increased to 7%, 13%, and 36% when
the V20 percentages were 22–31%, 32–40%, and >40%,
respectively. This risk of RP could be reduced by up to
10% by using intensity-modulated radiotherapy (IMRT),
without compromising tumor-dose delivery [6]. Neverthe-
less, ways of minimizing RT-induced side effects such as
RP, while continuing to achieve reasonable local control of
NSCLC, remain a challenge for radiation oncologists.td. This is an Open Access article distributed under the terms of the Creative
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Abbreviations: NSCLC Non-small cell lung cancer, RUL Right upper lobe, RLL
Right lower lobe, LUL Left upper lobe, LLL Left lower lobe, PTV Planning
target volume.
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fusion and/or ventilation imaging has been shown to
be important in evaluating pulmonary toxicity after RT
for NSCLC [7-10]. Several techniques exist for pulmonary
ventilation imaging, including single photon emission
computed tomography and X-ray CT (SPECT-CT) [7,8],
hyperpolarized helium-3 magnetic resonance imaging
(3He-MRI) [9,10], and inert xenon CT (Xe-CT) [11]. How-
ever, although all these imaging modalities can provide
useful ventilation information, each has serious drawbacks,
such as high cost, low resolution, long scan time and/or
low accessibility [12].
Four-dimensional (4D) CT imaging is an exciting new
form of ventilation imaging, which consists of three-
dimensional (3D) CT images resolved into different
phases of the breathing cycle [13]. 4D-CT is becoming
widely available and has shown great promise for treat-
ment planning. Because 4D-CT data are relatively easy
to acquire during treatment planning, calculating ventila-
tion maps from 4D-CT data only involves additional
image processing, and does not add any extra dosimetric
or monetary cost to the patient. Moreover, 4D-CT ventila-
tion imaging has higher resolution, a shorter scan time and
is more accessible than other existing techniques. Previous
studies have investigated the incorporation of 4D-CT
ventilation imaging into RT treatment planning [8,14-16].
For example, Castillo et al. [8] examined different ways of
calculating ventilation from 4D-CT data to estimate local
volume changes, and compared the results with those
obtained clinically from SPECT ventilation. Ding et al.
[14] explored the changes in lung ventilation after RT, and
Yamamoto et al. [15] and Yaremko et al. [16] discussed the
idea of designing treatment plans to avoid high-ventilation
areas of the lung. However, most of these studies consid-
ered treatment planning based on fixed-beam arrange-
ments, and to the best of our knowledge, no studies have
compared the use of different beam arrangements.
The primary purpose of this study was to investigate
the feasibility of combining IMRT with ventilation maps
calculated from 4D-CT data, and to compare the benefits




This study was approved by the Institutional Review Board
(IRB) at the Affiliated Tumor Hospital of Guangzhou
Medical University. Informed consent was obtained from
each patient, in accordance with the IRB regulations.
Sixteen consecutive patients with Stage III-IV and recur-
rent NSCLC who previously underwent IMRT were in-
cluded. The characteristics of the patients are presented
in Table 1.The 4D-CT data sets were obtained using a
16-detector row spiral CT scanner (Lightspeed 16; GEMedical Systems, Milwaukee, WI, USA) in cine mode
with a 2.5-mm slice covering the entire chest. A medical
physicist was present during each CT scan to ensure
that the patient’s breathing was not erratic. To compute
the pulmonary ventilation, the paired 4D-CT images at
the peak-exhale and peak-inhale phases were selected in
this study. Additional details regarding the use of 4D-CT
have been published in our previous work [17].
4D-CT pulmonary ventilation imaging
Processing 4D-CT pulmonary ventilation imaging involved
three steps. Firstly, paired 4D-CT images obtained at the
peak-exhale and peak-inhale phases were transferred to our
self-developed ventilation imaging software (ZHANGShuxu
4D-CT LF, V1.0) for ventilation computation. Deformable
image registration (DIR) was then used to link correspond-
ing lung volume elements between the peak-exhale and
peak-inhale 4D-CT data sets, to produce a displacement
vector field (DVF). We used 3D-image registration based
on a B-spline elastic algorithm, the geometric accuracy of
which has been validated previously [18]. 3D-image regis-
tration was used to create a voxel-by-voxel displacement
map showing the motion of the lung tissue as a function
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created by quantitative analysis of the DVF. In this study,
the Jacobian determinant of deformation [19] was used to
measure the degree of regional lung expansion that was dir-
ectly related to specific volume change. The Jacobian deter-
minant of DVF was calculated for each voxel in the lung
and used to represent local tissue expansion (or contrac-
tion). The regional ventilation was given by:
V x; y; zð Þ ¼
1þ ∂ux x; y; zð Þ
∂x
∂ux x; y; zð Þ
∂y
∂ux x; y; zð Þ
∂z
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where the function represents the displacement vector,
mapping the voxel at each point of a peak-exhale image
to the corresponding position on a peak-inhale image. Inb
GTV
Functional Lung
Figure 1 The functional lung of ventilation maps in a case. (a)
Fusion imaging of CT image and pulmonary ventilation extracted
from the generated deformation field; and (b) highly functional lung
regions contoured on (a). In this study, regions in the top 30% for
ventilation in the ventilation image were defined as functional lung
structures to avoid in the functional IMRT plans.addition, the functional lung of ventilation mapping
procedure was shown in Figure 1.
IMRT planning
The Oncentra treatment planning system, version 4.1
(Nucletron V.B., Veenendaal, The Netherlands) was used
to delineate the target volumes and organs at risk
(OARs) and for IMRT planning and dose calculation.
Both target volumes and OARs, including the spinal
cord, esophagus, heart, and lungs, were contoured and
approved on peak-exhale 4D-CT images by an attending
physician. The gross tumor volume to clinical target
volume (CTV), and CTV to planning target volume
(PTV) margins were 6–8 mm and 8 mm, respectively.
Planning OAR volumes were generated for the spinal
cord and esophagus by adding 5.0-mm isotropic mar-
gins. In addition, functional lung regions were defined
from 4D-CT ventilation images for functional planning,
as described for other IMRT studies for NSCLC [16]. In
this study, regions in the top 30% for ventilation in the
4D-CT-based ventilation image were set as functional
lung structures to avoid in the functional IMRT plans.
Moreover, the total lung and functional lung represented
the total volume and the functional part of the sum of
both lungs.
All the IMRT plans were designed to deliver 66 Gy in
33 fractions to cover 95% of the PTV. The radiation dose
distributions were calculated using the collapsed cone
algorithm on a graphics processing unit (GPU). Four inde-
pendent treatment plans were designed for each case in
this study. First, two anatomically-constrained plans was
generated without the incorporation of pulmonary ventila-
tion information, with the main goal of minimizing theTable 2 IMRT planning goals and constraints
Structure Constraint
PTV Min. dose ≥65 Gy
Max. dose ≤70 Gy
Volume receiving ≥66 Gy more than 95%
Total lung Dmean 20 Gy
Volume receiving ≥20 Gy less than 30%
Volume receiving ≥30 Gy less than 20%
Spinal cord Max. point dose ≤40 Gy
Heart Volume receiving ≥40 Gy less than 100%
Volume receiving ≥45 Gy less than 67%
Volume receiving ≥60 Gy less than 33%
Esophagus Volume receiving ≥55 Gy less than 35%
Skin Max. dose ≤70 Gy
Functional lunga Volume receiving ≥20 Gy less than 20%
Volume receiving ≥10 Gy less than 35%
Abbreviations: IMRT Intensity-modulated radiotherapy, PTV Planning target volume,
Min. Minimum, Max. Maximum, Dmean Mean dose.
afor functional-constrained plan.
Table 3 Comparison of PTV parameters between different plans
Anatomic plan Functional plan
Paremeter FESB FMOB P value FESB FMOB P value
Conformity indexa 1.01±0.01 1.013±0.02 0.148 1.01±0.02 1.02±0.02 0.617
Homogeneity indexb 1.06±0.02 1.07±0.03 0.069 1.07±0.02 1.07±0.03 0.837
MUs 485±202 497±207 0.403 492±189 500±223 0.682
Mean dose (Gy) 67.11±0.05 67.18±0.54 0.637 67.09±0.40 67.04±0.42 0.785
Abbreviations: PTV Planning target volume, MUs Monitor units, FESB Five equally-spaced beams, FMOB Five manually optimized beams; Data presented as
mean±standard deviation.
aConformity index = cover factor × spill factor, where cover factor defined as relative PTV volume receiving ≥66 Gy, and spill factor defined as ratio of PTV
receiving ≥66 Gy to total volume receiving 66 Gy.
bHomogeneity index = D5%/D95% , where Dx% is minimum dose in x% of PTV.
Wang et al. Radiation Oncology 2014, 9:184 Page 4 of 8
http://www.ro-journal.com/content/9/1/184volumes of total normal lung and other normal tissues
that were irradiated above their tolerance levels (Table 2).
Second, two functionally-constrained plans incorporating
pulmonary ventilation information was generated with
additional constraints to reduce the V10 and V20 of the
identified functional lung regions (Table 2). In addition,
dosimetric differences between beam arrangements were
evaluated using five equally spaced beams (FESB) posi-
tioned every 72° from the anterior and lateral directions,
and five manually optimized beams (FMOB) for both the
anatomic and functional plans. In plan with FMOB,
gantry angles were changed to avoid critical OARs, highly
functional lung regions and the non-involved total lung
regions.
Data analysis and statistical methods
The quality of the IMRT plans was evaluated by comparing
the metrics of PTVs using common dose-volume parame-
ters such as the conformity index (CI), heterogeneity index
(HI), mean dose (Dmean), and total number of monitor units
(MUs). Dosimetric parameters including the percentage of
lung volume receiving >5 Gy, >10 Gy, >20 Gy, and >30 Gy
were calculated for the functional lung (FLV5, FLV10, FLV20,
and FLV30, respectively) and total lung (TLV5, TLV10,
TLV20, and TLV30, respectively). Regarding the other crit-
ical structures, the maximum dose (Dmax) delivered to theTable 4 Comparison of dosimetric parameters for total and fu
the same beam setups
Beam setup Total lung
Plan TLV5 TLV10 TLV20
FESB Anatomic plan 61.7±12.9 46.7±11.4 30.7±5.3
Functional plan 60.3±12.8 43.5±11.3 29.1±6.7
P value 0.002 0.001 0.051
FMOB Anatomic plan 35.0±12.5 29.1±9.8 23.3±7.1
Functional plan 33.3±10.1 27.6±8.5 23.3±6.9
P value 0.395 0.226 0.945
Abbreviations: TLVx Percentage of volume of total lung receiving > x Gy, FLVx Perce
beams, FMOB Five manually optimized beams, Data presented as mean±standard dspinal cord, the Dmean and Dmax delivered to esophagus,
and the V40, V45, and V60 delivered to the heart were also
quantified and compared between the anatomic and
functional plans with different beam arrangements.
Statistical analysis was performed using SPSS 19.0 statis-
tical software (SPSS Inc., Chicago, IL, USA). Volumetric
and dosimetric parameters for the target volumes and
OARs were characterized using descriptive statistics.
The dosimetric differences between the application of
FESB and FMOB were evaluated for each plan and
compared using paired, two tailed t-tests. A P value < 0.05
was considered statistically significant.
Results
All the anatomically-constrained and functional-constrained
plans developed in this study were clinically acceptable.
There were no significant differences in PTV dosimetric
parameters such as CI, HI, and Dmean (P > 0.05) between
the anatomic and functional plans using FMOB or FESB,
as shown in Table 3. In addition, the functional plans
resulted in slightly higher MUs than the anatomic plans,
as expected given the additional constraints for functional
planning, though the differences were not significant.
Table 4 shows the dosimetric parameters of the total
and functional lung for the same beam arrangements be-
tween anatomic and functional plan. For FESB, functionalnctional lung between anatomic and functional plan for
Functional lung
TLV30 FLV5 FLV10 FLV20 FLV30
21.2±5.3 54.2±21.7 42.5±22.1 26.3±20.7 17.0±12.6
20.9±5.6 52.4±20.7 37.1±12.2 21.1±5.8 16.7±6.8
0.232 0.005 0.029 0.018 0.911
20.1±6.4 30.2±18.5 24.1±11.5 17.8±7.5 16.2±7.0
20.1±6.1 29.2±18.3 23.0±14.8 16.7±9.7 14.7±9.5
0.904 0.757 0.575 0.234 0.258
ntage of volume of functional lung receiving > x Gy, FESB Five equally-spaced
eviation.
Figure 2 Comparison of the dose distribution between an anatomic plan with (a) five equally-spaced beam arrangements; and (b) five
manually optimized beam arrangements; a functional plan with (c) five equally-spaced beam arrangements; and (d) five manually
optimized beam arrangements.
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tional lung in average compared with those in anatomic
plans, with significant reductions (P < 0.05) in lower dose
region (V5, V10, and V20); While for FMOB, functional
plans resulted in slightly lower doses to the total and
functional lung than those in anatomic plans, though the
differences were not statistically significant (P > 0.05).
Figure 2 shows the isodose distributions for both ana-
tomic and functional plans and for both beam arrange-
ments as an example. Both anatomic and functional plans
showed that the highly functional lungs were spared in
FMOB, compared with FESB. In particular, the 20- and
30-Gy isodose curves were significantly distorted and
moved out of the left lung, which contained large part of
highly functional lung. The dosimetric parameters for the
total and functional lung regions between different beam
arrangements are shown in Tables 5 and 6. In both the
anatomic and functional plans, V5, V10, and V20 in the
total and functional lung regions were significantly lowerTable 5 Comparison of dosimetric parameters for total lung b
Beam arrangement Anatomic plan
TLV5 TLV10 TLV20
FESB 61.7±12.9 46.7±11.4 30.7±5.3
FMOB 35.0±12.5 29.1±9.8 23.3±7.1
P value <0.001 <0.001 <0.001
Abbreviations: TLVx Percentage of volume of total lung receiving > x Gy, FESB Five e
as mean±standard deviation.in FMOB, compared with FESB (P < 0.05), though there
was no significant difference for V30 (P > 0.05). The same
results were demonstrated using a dose-volume histogram
(DVH) (Figure 3).
The doses to the spinal cord, heart, and esophagus
using the different beam arrangements are shown in
Table 7. The maximum doses delivered to the spinal cord
in the anatomic and functional plans were slightly lower
for FMOB compared with FESB, but the difference was
not significant (P > 0.05). However, the doses delivered to
the esophagus were significantly lower for FMOB than for
FESB (P < 0.05); the Dmean values for the esophagus in the
anatomic plan were 22.0 Gy and 16.3 Gy for FESB and
FMOB, respectively, while the equivalent Dmean values in
the functional plan were 22.7 Gy and 16.2 Gy. In the heart,
there were significant differences between the FESB and
FOMB plans in terms of V60 for both the anatomic and
functional plans (P < 0.05), but the differences were not
significant for V40 and V45 (P > 0.05).etween different beam arrangements
Functional plan
TLV30 TLV5 TLV10 TLV20 TLV30
21.2±5.3 60.3±12.8 43.5±11.3 29.1±6.7 20.9±5.6
20.1±6.4 33.3±10.1 27.6±8.5 23.3±6.9 20.1±6.1
0.417 <0.001 <0.001 <0.001 0.231
qually-spaced beams, FMOB Five manually optimized beams, Data presented
Table 6 Comparison of dosimetric parameters for functional lung between different beam arrangements
Beam arrangement Anatomic plan Functional plan
FLV5 FLV10 FLV20 FLV30 FLV5 FLV10 FLV20 FLV30
FESB 54.2±21.7 42.5±22.1 26.3±20.7 17.0±12.6 52.4±20.7 37.1±12.2 21.1±5.8 16.7±6.8
FMOB 30.2±18.5 24.1±12.0 17.8±8.9 16.2±7.0 29.2±18.3 23.0±14.8 16.7±9.7 14.7±9.5
P value <0.001 <0.001 0.049 0.754 <0.001 <0.001 0.001 0.244
Abbreviations: FLVx Percentage of volume of functional lung receiving > x Gy, FESB Five equally-spaced beams, FMOB Five manually optimized beams, Data
presented as mean±standard deviation.
b
Figure 3 Dose-volume histogram (DVH) changes in planning target volume (PTV), total lung, and functional lung in a sample case.
(a) DVH of an anatomic-constrained IMRT treatment plan with five equally-spaced beam arrangements (solid lines) and five manual optimization
beam arrangements (broken lines). (b) DVH changes are also shown in a functional-constrained IMRT plan using highly functional lung as an
avoidance structure with different beam arrangements.
Wang et al. Radiation Oncology 2014, 9:184 Page 6 of 8
http://www.ro-journal.com/content/9/1/184
Table 7 Comparison of dosimetric parameters for OARs between different beam arrangements
Parameter Anatomic plan Functional plan
FESB FMOB P value FESB FMOB P value
Spinal cord
Dmax (Gy) 37.1±7.1 32.7±13.3 0.101 37.1±7.8 33.0±7.0 0.113
Esophagus
Dmean (Gy) 22.0±10.4 16.3±11.6 0.001 22.7±10.3 16.2±11.6 0.001
Dmax (Gy) 58.1±9.6 53.4±12.0 0.013 57.6±10.4 53.2±12.4 0.020
Heart
V40 17.2±11.1 21.7±16.3 0.144 17.2±11.7 20.9±15.7 0.167
V45 13.1±9.1 17.9±13.5 0.057 13.4±10.1 16.3±13.0 0.194
V60 5.9±4.6 10.3±9.8 0.032 5.8±5.0 9.7±9.9 0.048
Abbreviations: OARs Organs at risk, Dmax Maximum dose, Dmean Mean dose, Vx Percentage of volume receiving > x Gy, FESB Five equally-spaced beams, FMOB Five
manually optimized beams, Data presented as mean±standard deviation.
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Current RT planning aimed at limiting lung toxicity
assumes a uniform distribution of pulmonary function,
and fails to take account of spatial and temporal patterns.
Previous studies demonstrated that the incidence and
seriousness of RP were positively correlated with total
radiation dose to the lungs [20]. Clarification of the
relationship between radiation dose and changes in
pulmonary function may help to predict and reduce
RT-induced pulmonary toxicity. Decreasing the radiation
dose to functional lung areas and directing the rays to the
parts with perfusion/ventilation defects may help to
protect highly functional lung regions and thus reduce
the incidence and seriousness of RP [21].
Lung function can be evaluated by functional imaging
modalities such as SPECT, PET/CT and 3He-MRI. How-
ever, these imaging modalities are not yet widely available
in China, and their routine application in clinical practice
would be associated with a long scan time and high costs
to patients. We therefore assessed the value of acquiring
functional information using the newly-reported 4D-CT-
based ventilation imaging, which has the advantage that
ventilation images can be calculated using only an add-
itional processing step (i.e., DIR).
The results of this study showed that 4D-CT-based
ventilation information could be used to reduce the radi-
ation dose to the highly functional areas of the lung,
assessed by FLV5–20, compared with anatomic planning
alone, which was consistent with the results reported in
previous published papers [15,16]. Moreover, our findings
indicated that both anatomic and functional treatment
plans using FMOB could reduce the functional lung
regions exposed to lower doses (FLV5–20), without com-
promising target volume coverage, compared with FESB.
In addition to the observed improvements in dose-volume
parameters of the functional lung, this study also identi-
fied dosimetric improvements in the low-dose zones of
total lung, especially in terms of improved V20 volume.These results were compatible with that of a recent study
investigating functional IMRT treatment planning using
4D-CT images [22]. Functional plans using an optimal
beam arrangement aimed at preserving the functional
lung did not compromise the DVHs of OARs, such as
the spinal cord, esophagus, and heart, which may be an
additional important clinical factor. These results also
demonstrated that this technique could be applied safely to
RT treatments for patients with NSCLC, without exceeding
the dose-volume tolerances of OARs.
Although significant dosimetric improvements were
observed in the lower-dose regions of functional and
total lung, the clinical relevance of these improvements
in terms of reducing the risk of RT-induced pulmonary
toxicity remains unclear. There is currently insufficient
outcome data to confirm the correlation between func-
tional lung dose-volume parameters and pulmonary toxicity
endpoints, and further studies are needed to determine if
dosimetric reductions to functional lung will translate into
clinical benefits for NSCLC patients.
Although, several existing studies have validated the
4D-CT-based ventilation imaging modality [23,24], its
regional physiologic accuracy has not been validated in
patients. In addition, temporal changes in regional ventila-
tion to a segment of lung previously impaired by compres-
sion from a local tumor might occur during the course of
RT. A possible explanation of these changes is that the
shrinkage of lung tumor volume in response to IMRT
treatment may result in increased ventilation as a result of
reopening of the airways [25].
Ongoing studies aim to address the above issues by
long-term follow-up of a preliminary patient cohort with
known functional lung dose-volume parameters. The
physiologic accuracy of 4D-CT-based ventilation imaging
will be assessed in these patients by quantifying the impact
of temporal changes in ventilation during the course of
RT and evaluating pulmonary function and morbidity
outcomes after radical RT.
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In conclusion, this study demonstrated the feasibility of
functional treatment planning using 4D-CT-based pul-
monary ventilation information to identify structures to
avoid. The results further indicated the dosimetric benefit
of optimal beam arrangement compared with fixed-beam
arrangement in IMRT treatment planning, in terms of
preserving functional lung at lower radiation doses in
patients with NSCLC.
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